Submitted:
22 September 2025
Posted:
23 September 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
1.1. Amelogenesis Imperfecta (AI) and Its Consequences
1.2. Advantages of Online Social Network for Patients
- Access to genuine, unprompted patient perspectives. Patients, life science industry and regulatory authorities are united in their goal to reduce the disease burden of patients by closing remaining unmet needs. Patients have, however, not always been systematically and consistently involved in the drug development process. Recognizing this gap, regulatory bodies worldwide have initiated patient-focused drug development (PFDD) initiatives to foster a more systematic involvement of patients in the drug development process and to ensure that outcomes measured in clinical trials are truly relevant to patients and represent significant improvements to their quality of life. Patients often share honest, detailed personal experiences—both emotional and physical—on Facebook and forums. These candid insights reveal what truly matters to them. Such organic conversations provide access to the “lay perspective,” capturing daily challenges, fears, treatment outcomes, and unmet needs that traditional surveys or clinical settings may miss [45].
- Identifying gaps in patient support and communication. Comment analysis helps uncover frequently asked questions, misconceptions, or frustrations among patients. For instance, the analysis of community exchanges threads shows which concerns recur most often, guiding the development of more relevant content, targeted educational materials, and improved support services. Patients and family members in rare disease social media groups appear interested in engaging with genetic counselors through social media [46], particularly for individualized support. This form of engagement on social media is not meant to replace the current structure and content of genetic counseling (GC) services, but genetic counselors could more actively use social media as a communication tool to address gaps in knowledge and awareness about genetics services and gaps in accessible patient information.
- Real-time insights and emerging trend detection. Unlike traditional feedback methods, social media comments arrive instantly—giving healthcare organizations a near real-time “pulse” on how patients feel about treatments, services, or public health issues. This allows for faster response to misinformation, sudden sentiment changes, or emerging health concerns.
- Enhancing patient engagement [5,47]. Actively monitoring and responding to Facebook comments demonstrates that caregivers and organizations are listening and care, which builds trust. Engaging with comments—especially addressing negative feedback—can improve reputation and even boost content reach on platforms like Facebook.
- Quantifying sentiment and satisfaction [48,49]. Sentiment analysis tools applied to Facebook data can help measure patient satisfaction, gauge overall sentiment trends, and spot early signs of issues. Studies have shown that hospitals with active Facebook engagement often receive higher patient satisfaction and recommendation rates.
- Guiding product development and healthcare policy [50,51]. For pharmaceutical companies and drug developers, insights from Facebook can help inform patient- centric medicine development. It enables identification of unmet needs, emotional impact of diseases, treatment preferences, and real-world patient priorities—data which regulatory agencies increasingly view as essential.
1.3. Limitations of Previous Studies and Our Objectives
2. Materials and Methods
2.1. The French Facebook Group Amelogenesis Imperfecta
2.2. Design and Tools
2.2.1. Data Extraction
2.2.2. Data Analysis
- Similarity analysis. This analysis, based on graph theory, is often used by social representations researchers. It allows to identify the words co-occurrences, providing information on the words connectivity thus helping to identify the structure of a text corpus content. It also allows to identify the shared parts and specificity according to the descriptive variables identified in the analysis.
- Method of Descending Hierarchical Analysis (DHA). The content and text segments are clustered according to their vocabularies and distributed according to the reduced forms frequencies. Using matrices that cross reduced forms with textual segments, the DHA method allows you to obtain a definitive classification. It is aimed at obtaining clusters with similar vocabulary within, but different from other segments. A dendrogram will be dis- played showing clusters relations. The software calculates descriptive results of each cluster conforming to its main vocabulary (lexic) and words with asterisk (variables). Furthermore, it provides the users with another way of presenting data, derived from a correspondence factor analysis. Based on the chosen clusters, the software calculates and provides the most typical TS of each cluster, giving context to them.
2.3. Ethics
3. Results
3.1. Similarity Analysis and Clustering
- The word “dent” (tooth) forms the central lexical node, with numerous connections to everyday terms such as “fils” (son), “fille” (daughter), “mettre” (put), “perdre” (lose), “petit” (small), “problème” (problem), indicating real-life, family-centered experiences related to dental symptoms. This cluster is strongly linked to “dentiste” (dentist), which is in turn connected to terms like “traite- ment” (treatment), “rendez-vous” (appointment), “avis” (opinion), “diagnostiquer” (diagnose), highlighting the central role of healthcare and professional consultations;
- A second semantic hub is organized around “maladie” (disease), connected to “génétique” (genetic), “enfant” (child), “rare”, “connaître” (to know). This reflects a medicalized view of the condition, often framed in terms of inheritance, diagnosis, and rarity. The presence of terms such as “pétition” (petition), “centre” (center), “changer” (change), “donner” (give) suggests a broader collective or advocacy dimension, possibly parental or patient-led efforts seeking recognition or policy change;
- Finally, the word “amélogenèse” (amelogenesis) appears in direct connection with “imparfait” (imperfect), “atteindre” (affect), “association”, reflecting the shared awareness of the condition’s name and the need for information-sharing and support, as seen in related terms like “photo”, “groupe”, “partager” (share).
3.2. Correspondence Analysis and Factorization
- Factor 1 (horizontal axis): Explains 49.34% of the variance. This factor 1 distinguishes Clinical vs. Activist Dimension. The right side (Red/Green/Blue) focuses on clinical, genetic, and symptom-based discourse; the left side (Purple) focuses on community, activism, media, and public communication This axis opposes individual/medical experience to collective/social mobilization;
- Factor 2 (vertical axis): Explains 23.26% of the variance. This factor 2 distinguishes Technical vs. Personal/Descriptive Dimension. The top (blue) is related to lexicon rich in concrete dental symptoms and care (e.g., "molaire", "résine", "douleur"); the bottom (red/green) emphasizes institutional, procedural, or psychological aspects (e.g., "rendez-vous", "médecin", "traitement", "hôpital").
3.3. Thematic Analysis of Comments and Exchanges
- Class 1 (in red): Medical Professionals and Access to Care (21%), with the following top words: "spécialiste", "docteur", "rendez-vous", "dentiste", "médecin", "hôpital", "centre", "travail", "connaître", "répondre". This class reflects a discourse focused on accessing the healthcare system: it centers around interactions with special- ists, doctors, and institutions. The presence of location- specific terms (e.g., Lyon, Bordeaux, Montpellier) and verbs like répondre, prendre suggest issues related to appointments, delays, and logistics. We propose to label this class "Healthcare navigation and access difficulties";
- Class 2 (in green): Genetic and Clinical Nature of the Disease (19%), with the following top words: "génétique", "maladie", "imparfaite", "gène", "enfant", "atteindre", "test", "amélogenèse", "transmettre". This class reflects a biomedical perspective of the condition. It includes genetic terms and refers to the transmission, testing, and emotional impact of amelogenesis imperfecta. Words like "chance", "vivre", "courage" suggest some existential or emotional framing of the diagnosis. We propose to label this class "Genetic disease framing and family impact";
- Class 3 (in blue): Description of Dental Symptoms (29.1%), with the following top words: "dent", "molaire", "couronne", "lait", "toucher", "poser", "incisive", "fils", "carie", "abîmer", "jaune". This is the most concrete and symptom-centered class, focusing on dental manifestations and terminology. It includes references to deciduous teeth ("lait"), materials ("résine"), stages ("sortie"), and treatments ("couronne"). This suggests parents or individuals are detailing clinical signs and treatment attempts. we propose to label this class "Dental symptoms and treatment experiences";
- Class 4 (in purple): Advocacy, Community, and Visibility (31%), with the following top words: "com", "pétition", "partager", "association", "signature", "signer", "reconnaissance", "député", "participer", "article". This class stands apart as a collective, activist discourse. It includes words related to online engagement, petitioning, awareness-raising, and media participation. The use of "com", "admin", "signature", "député" suggests efforts to gain recognition for the disease and mobilize institutional support. We propose to label this class "Community mobilization and advocacy".
4. Discussion
5. Conclusions
Funding
Institutional Review Board Statement
Acknowledgments
Conflicts of Interest
References
- Chirumamilla, S.; Gulati, M. Patient education and engagement through social media. Curr Cardiol Rev. 2021, 17, 137–143. [Google Scholar] [CrossRef]
- Gupta, P.; Khan, A.; Kumar, A. Social media use by patients in health care: A scoping review. Int J Healthc Manag. 2022, 15, 121–131. [Google Scholar] [CrossRef]
- Long, J.C.; et al. Needs of people with rare diseases that can be supported by electronic resources: A scoping review. BMJ Open. 2022, 12, e060394. [Google Scholar] [CrossRef]
- Chen, J.; Wang, Y.; et al. Social media use for health purposes: Systematic review. J Med Internet Res. 2021, 23, e17917. [Google Scholar] [CrossRef]
- Liddy, C.; Hunter, Z.; Mihan, A.; Keely, E. Use of Facebook as part of a social media strategy for patient engagement. Can Fam Physician. 2017, 63, 251–252. [Google Scholar]
- Stewart, S.A.; Abidi, S.S.R. Applying social network analysis to understand the knowledge sharing behaviour of practitioners in a clinical online discussion forum. J Med Internet Res. 2012, 14, e1982. [Google Scholar] [CrossRef]
- Hu, H.; et al. Review of social networks of professionals in healthcare settings—where are we and what else is needed? Glob Health. 2021, 17, 139. [Google Scholar] [CrossRef]
- Crisan-Dabija, R.A.; Cernomaz, A.; Mihaescu, T.; Filipeanu, D. Developing a successful medical team using WhatsApp™ and social media (1 year follow up). 2019. [CrossRef]
- Francis, T.; et al. Exploring the use of social network analysis methods in process improvement within healthcare organizations: A scoping review. BMC Health Serv Res. 2024, 24, 1030. [Google Scholar] [CrossRef]
- Pomare, C.; Long, J.C.; Churruca, K.; Ellis, L.A.; Braithwaite, J. Social network research in health care settings: Design and data collection. Soc Netw. 2022, 69, 14–21. [Google Scholar] [CrossRef]
- De Las Heras-Pedrosa, C.; Rando-Cueto, D.; Jambrino-Maldonado, C.; Paniagua-Rojano, F.J. Analysis and study of hospital communication via social media from the patient perspective. Cogent Soc Sci. 2020, 6, 1718578. [Google Scholar] [CrossRef]
- Turk, A.; Fleming, J.; Powell, J.; Atherton, H. Exploring UK doctors’ attitudes towards online patient feedback: Thematic analysis of survey data. Digital Health. 2020, 6, 2055207620908148. [Google Scholar] [CrossRef]
- Atherton, H.; Fleming, J.; Williams, V.; Powell, J. Online patient feedback: A cross-sectional survey of the attitudes and experiences of United Kingdom health care professionals. J Health Serv Res Policy. 2019, 24, 235–244. [Google Scholar] [CrossRef]
- Lee, B.Y.; et al. Social network analysis of patient sharing among hospitals in Orange County, California. Am J Public Health. 2011, 101, 707–713. [Google Scholar] [CrossRef]
- Eysenbach, G.; Powell, J.; Englesakis, M.; Rizo, C.; Stern, A. Health related virtual communities and electronic support groups: Systematic review of the effects of online peer to peer interactions. BMJ. 2004, 328, 1166. [Google Scholar] [CrossRef]
- Doyle, T.A.; Vershaw, S.L.; Conboy, E.; Halverson, C.M. Improving social media-based support groups for the rare disease community: Interview study with patients and parents of children with rare and undiagnosed diseases. JMIR Hum Factors. 2024, 11, e57833. [Google Scholar] [CrossRef]
- Colineau, N.; Paris, C. Talking about your health to strangers: Understanding the use of online social networks by patients. New Rev Hypermedia Multimed. 2010, 16, 141–160. [Google Scholar] [CrossRef]
- Jacobs, W.; Amuta, A.O.; Jeon, K.C. Health information seeking in the digital age: An analysis of health information seeking behavior among US adults. Cogent Soc Sci. 2017, 3, 1302785. [Google Scholar] [CrossRef]
- Wang, X.; Shi, J.; Kong, H. Online health information seeking: A review and meta-analysis. Health Commun. 2021, 36, 1163–1175. [Google Scholar] [CrossRef]
- Aldred, M.; Savarirayan, R.; Crawford, P. Amelogenesis imperfecta: A classification and catalogue for the 21st century. Oral Dis. 2003, 9, 19–23. [Google Scholar] [CrossRef]
- Koruyucu, M.; Bayram, M.; Tuna, E.B.; Gencay, K.; Seymen, F. Clinical findings and long-term managements of patients with amelogenesis imperfecta. Eur J Dent. 2014, 8, 546–552. [Google Scholar] [CrossRef]
- Oz, U.; Altug, A.T.; Arikan, V.; Orhan, K. Radiographic evaluation of craniofacial structures associated with amelogenesis imperfecta in a Turkish population: A controlled trial study. Oral Radiol. 2010, 26, 89–94. [Google Scholar] [CrossRef]
- Appelstrand, S.; Robertson, A.; Sabel, N. Patient-reported outcome measures in individuals with amelogenesis imperfecta: A systematic review. Eur Arch Paediatr Dent. 2022, 23, 885–895. [Google Scholar] [CrossRef]
- Pousette Lundgren, G.; Karsten, A.; Dahllöf, G. Oral health-related quality of life before and after crown therapy in young patients with amelogenesis imperfecta. Health Qual Life Outcomes. 2015, 13, 197. [Google Scholar] [CrossRef]
- Martin, M.; Gowda, S.; Foster Page, L.; Thomson, W.M. Oral health-related quality of life in Northland Māori children and adolescents with Polynesian amelogenesis imperfecta. Front Dent Med. 2024, 5, 1485419. [Google Scholar] [CrossRef]
- Borges, T.S.; Vargas-Ferreira, F.; Kramer, P.F.; Feldens, C.A. Impact of traumatic dental injuries on oral health-related quality of life of preschool children: A systematic review and meta-analysis. PLoS One. 2017, 12, e0172235. [Google Scholar] [CrossRef]
- Hashem, A.; Kelly, A.; O’Connell, B.; O’Sullivan, M. Impact of moderate and severe hypodontia and amelogenesis imperfecta on quality of life and self-esteem of adult patients. J Dent. 2013, 41, 689–694. [Google Scholar] [CrossRef]
- Coffield, K.D.; et al. The psychosocial impact of amelogenesis imperfecta. J Am Dent Assoc. 2005, 136, 620–630. [Google Scholar] [CrossRef]
- Parekh, S.; Almehateb, M.; Cunningham, S.J. How do children with amelogenesis imperfecta feel about their teeth? Int J Paediatr Dent. 2014, 24, 326–335. [Google Scholar] [CrossRef]
- Lyne, A.; Parekh, S.; Patel, N.; Lafferty, F.; Brown, C.; Rodd, H.; Monteiro, J. Patient-reported outcome measure for children and young people with amelogenesis imperfecta. Br Dent J. 2021, (1-6). [Google Scholar] [CrossRef]
- Trentesaux, T.; Rousset, M.; Dehaynin, E.; Laumaillé, M.; Delfosse, C. 15-year follow-up of a case of amelogenesis imperfecta: Importance of psychological aspect and impact on quality of life. Eur Arch Paediatr Dent. 2013, 14, 47–51. [Google Scholar] [CrossRef]
- Scheffel, D.L.S.; et al. Esthetic dental anomalies as motive for bullying in schoolchildren. Eur J Dent. 2014, 8, 124–128. [Google Scholar] [CrossRef]
- Broutin, A.; Blanchet, I.; Canceill, T.; Noirrit-Esclassan, E. Association between dentofacial features and bullying from childhood to adulthood: A systematic review. Children. 2023, 10, 934. [Google Scholar] [CrossRef]
- Herath, C.; Perera, I.; Jayasooriya, P.; Perera, M. Experiences of mothers of affected children on family impact of amelogenesis imperfecta: Findings of a qualitative explorative study from Sri Lanka. Interventions in Pediatric Dentistry Open Access Journal. 2021. [Google Scholar]
- Alqadi, A.; O’Connell, A.C. Parental perception of children affected by amelogenesis imperfecta (AI) and dentinogenesis imperfecta (DI): A qualitative study. Dentistry Journal. 2018, 6, 65. [Google Scholar] [CrossRef]
- Duarte-Rodrigues, L.; et al. Oral disorders associated with the experience of verbal bullying among Brazilian school-aged children: A case-control study. J Am Dent Assoc. 2020, 151, 399–406. [Google Scholar] [CrossRef]
- Farmer, A.D.; Bruckner Holt, C.; Cook, M.; Hearing, S. Social networking sites: A novel portal for communication. Postgrad Med J. 2009, 85, 455–459. [Google Scholar] [CrossRef]
- Bender, J.L.; Jimenez-Marroquin, M.-C.; Jadad, A.R. Seeking support on Facebook: A content analysis of breast cancer groups. J Med Internet Res. 2011, 13, e15–e60. [Google Scholar] [CrossRef]
- Untas, A.; et al. The associations of social support and other psychosocial factors with mortality and quality of life in the Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol. 2011, 6, 142–152. [Google Scholar] [CrossRef] [PubMed]
- Vasilica, C.; et al. Identifying information needs of patients with IgA nephropathy using an innovative social media–stepped analytical approach. Kidney Int Rep. 2021, 6, 1317–1325. [Google Scholar] [CrossRef]
- Gaddy, A.; Topf, J. Facebook groups can provide support for patients with rare diseases and reveal truths about the secret lives of patients. Kidney Int Rep. 2021, 6, 1205–1207. [Google Scholar] [CrossRef]
- Titgemeyer, S.C.; Schaaf, C.P. Facebook support groups for rare pediatric diseases: Quantitative analysis. JMIR Pediatr Parent. 2020, 3, e21694. [Google Scholar] [CrossRef]
- Titgemeyer, S.C.; Schaaf, C.P. Facebook support groups for pediatric rare diseases: Cross-sectional study to investigate opportunities, limitations, and privacy concerns. JMIR Pediatr Parent. 2022, 5, e31411. [Google Scholar] [CrossRef]
- Oprescu, F.; Campo, S.; Lowe, J.; Andsager, J.; Morcuende, J.A.; et al. Online information exchanges for parents of children with a rare health condition: Key findings from an online support community. J Med Internet Res. 2013, 15, e24–e23. [Google Scholar] [CrossRef]
- Cimiano, P.; et al. Patient listening on social media for patient-focused drug development: A synthesis of considerations from patients, industry and regulators. Front Med (Lausanne). 2024, 11, 1274688. [Google Scholar] [CrossRef]
- Yabumoto, M.; et al. Perspectives of rare disease social media group participants on engaging with genetic counselors: Mixed methods study. J Med Internet Res. 2022, 24, e42084. [Google Scholar] [CrossRef]
- Alonso-Cañadas, J.; Galán-Valdivieso, F.; Saraite-Sariene, L.; Caba-Pérez, C. Committed to health: Key factors to improve users’ online engagement through Facebook. Int J Environ Res Public Health. 2020, 17, 1814. [Google Scholar] [CrossRef]
- Glivenko, O.; Yaroslavska, O.; Demchuk, A.; Poberezhets, V.; Mostovoy, Y. Use of online questionnaires, social networks and messengers for quick collecting epidemiological data among young people. 2020.
- Kondylakis, H.; et al. Patient empowerment through personal medical recommendations. Medinfo. 2015, 216, 1117. [Google Scholar]
- David, C.C.; San Pascual, M.R.S.; Torres, M.E.S. Reliance on Facebook for news and its influence on political engagement. PLoS One. 2019, 14, e0212263. [Google Scholar] [CrossRef]
- Khawaja, Z.A.; Ali, K.I.; Khan, S. Using Facebook for sexual health social marketing in conservative Asian countries: A systematic examination. J Health Commun. 2017, 22, 111–123. [Google Scholar] [CrossRef]
- Cohen, G.; Bessin, M.; Gaymard, S. Social representations, media, and iconography: A semiodiscursive analysis of Facebook posts related to the COVID-19 pandemic. Eur J Commun. 2022, 37, 629–645. [Google Scholar] [CrossRef]
- Rhaiem, M.; Chalbi, M.; Bousaid, S.; Zouaoui, W.; Chemli, M.A. Dental treatment approaches of amelogenesis imperfecta in children and young adults: A systematic review of the literature. J Esthet Restor Dent. 2024, 36, 881–891. [Google Scholar] [CrossRef]
- Lindunger, A.; Smedberg, J.I. A retrospective study of the prosthodontic management of patients with amelogenesis imperfecta. Int J Prosthodont. 2005, 18, 220–226. [Google Scholar] [CrossRef]
- Brough, P. Advanced research methods for applied psychology. 2018.
- Braun, V.; Clarke, V. Using thematic analysis in psychology. Qual Res Psychol. 2006, 3, 77–101. [Google Scholar] [CrossRef]
- Neuendorf, K.A. Content analysis and thematic analysis. In: Brough P, editor. Advanced research methods for applied psychology. Routledge; 2018. p. 211-223.
- Mennani, M.; Attak, E. An overview of using IRAMUTEQ software in qualitative analysis designs. In: Principles of conducting qualitative research in multicultural settings. 2024. p. 149-170.
- Pelentsov, L.J.; Fielder, A.L.; Laws, T.A.; Esterman, A.J. The supportive care needs of parents with a child with a rare disease: Results of an online survey. BMC Fam Pract. 2016, 17, 88. [Google Scholar] [CrossRef]
- Delisle, V.C.; et al. Perceived benefits and factors that influence the ability to establish and maintain patient support groups in rare diseases: A scoping review. Patient. 2017, 10, 283–293. [Google Scholar] [CrossRef]





Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).